ロード中...
Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings
Aims: Pharmacogenetic (PGx) tests are intended to improve therapeutic outcomes through predicting a patient's likelihood to respond to or experience an adverse effect from a specific treatment. In addition, PGx testing may also generate ancillary, or incidental, disease information unrelated to...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc.
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3306589/ https://ncbi.nlm.nih.gov/pubmed/22047505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/gtmb.2011.0118 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|